News for Anthera Pharmaceuticals, Inc. (ANTH)

Published at

May 6, 2024 8:34 PM

by marketscreener.com

mixed

mixed

NervGen Pharma : Notice of Meeting and Management Proxy Circular

NOTICE OF MEETING AND MANAGEMENT PROXY CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS ...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRKD.BA MRK.SN MRK.PA MRK.MX MRK KIN2.DE KGC.BA KGC K.TO JNJ DJNJ3.BA DJNJ2.BA ANTH 6MK.DE NGENF NGEN.V WPMN.MX WPM.TO WPM.L WPM

Read more →
Published at

Sep 18, 2022 10:34 AM

by etfdailynews.com

positive

positive

Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) Sees Large Decrease in Short Interest

Read Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) Sees Large Decrease in Short Interest at ETF Daily News

ANTH

Read more →
Published at

May 20, 2022 3:00 PM

by financialpost.com

mixed

mixed

Tentarix Biotherapeutics Announces the Strengthening of its Leadership and Advisory Teams

SAN DIEGO & VANCOUVER, British Columbia — Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based…

MSFT JNJ INCY DJNJ3.BA DJNJ2.BA SRZN OYST CDTX ANTH ACET 0HX7.L

Read more →